Uncategorized

Delhi High Court Blocks Unauthorized Streaming of India Tour 2025

by

In a landmark ruling, the Delhi High Court has granted a Dynamic+ injunction in favor of JioCinema and Disney+ Hotstar, blocking unauthorized streaming of the highly anticipated India Tour of England 2025.

Court Recognizes Clear Copyright Violation

Justice Sanjeev Narula of the Delhi High Court acknowledged that unauthorized streaming platforms were blatantly infringing copyright by broadcasting the live cricket series without permission. The court classified this as a “clear example of copyright infringement.”

The rights for the digital broadcast of the series are held exclusively by JioCinema and Disney+ Hotstar, through Viacom18 and Star India respectively.

What Is a Dynamic+ Injunction?

The Dynamic+ injunction allows rights holders to immediately block new rogue domains that illegally stream the matches, without needing to approach the court repeatedly. This proactive measure ensures that pirates can’t bypass bans by simply changing URLs or creating mirror sites.

The court emphasized that such swift actions are essential in dealing with the “menace of online piracy,” particularly during live sports broadcasts, where real-time viewership is commercially critical.

45 Rogue Websites Already Blocked

The order has already resulted in the blocking of over 45 pirate websites. Internet Service Providers (ISPs) have been directed to disable access to these domains.

Industry Applauds Ruling

The decision has been welcomed by broadcasters and content creators, who have long demanded stricter enforcement mechanisms against digital piracy.

A spokesperson from Viacom18 said, “This ruling protects our significant investments in sports content and sends a strong message to digital pirates.”

This article is based on publicly available information and legal filings. It does not constitute legal advice. All names, trademarks, and brands mentioned belong to their respective owners

Nikon’s Game-Changing Sensor for Filmmaking

by

Nikon’s latest innovation may change the future of filmmaking. The company has filed a new Japanese patent revealing a sensor capable of capturing both infrared (IR) and visible light. This new image sensor is designed specifically for cinema applications, opening doors for filmmakers to explore new creative possibilities.

📸 The Technology Behind the Patent

The patent introduces a multi-layer image sensor that can record infrared and visible spectrum data at the same time. Traditionally, filmmakers had to use external filters or multiple camera systems to achieve this. Nikon’s new sensor design removes that need.

By integrating the layers, Nikon’s sensor may capture IR and RGB information in a single frame. This could benefit cinematic storytelling, especially in stylized shoots, surveillance scenes, or night-for-day setups.

🎥 Why It Matters for Filmmakers

Creative Flexibility: With both types of data available, colorists and editors gain more control in post-production.

Efficiency on Set: Filmmakers can shoot with one camera setup, saving time and money.

Stylized Cinematic Looks: IR imagery offers surreal visual effects. It can enhance foliage, skin tones, and lighting in unique ways.

Advanced Filmmaking Tools: The sensor may also support better tracking and autofocus in challenging lighting conditions.

🛠️ Current Limitations

While the patent is promising, it remains in the conceptual stage. There’s no confirmation yet on whether or when this technology will reach Nikon’s product line. Developing a dual-layer sensor that balances image quality, light sensitivity, and dynamic range is complex.

📅 What’s Next?

Nikon has not made any official announcements tied to this patent. If developed commercially, this sensor could appear in Nikon’s upcoming cinema-focused cameras, potentially competing with brands like RED, ARRI, and Canon’s Cinema EOS line.

📢 Industry Buzz

The patent has already drawn attention from cinematographers and gear reviewers. Many believe Nikon is working to enter the high-end cinema camera market with cutting-edge technology.

📌 Conclusion

Nikon’s newly filed patent reveals a bold step toward hybrid IR-visible sensors for cinema applications. If successful, it could redefine how cinematographers approach lighting, editing, and storytelling.

Zen Technologies Unveils Patented Military Training Innovation

by

Zen Technologies Ltd., a leading provider of defence training and anti-drone solutions, has announced a major milestone in its innovation journey. The company has been granted a new patent for a cutting-edge technology that significantly enhances the effectiveness and reliability of laser-based military training systems.

The patent, titled “Single ILU Long Pass Filter,” is Zen Technologies’ 54th patent in India and 82nd globally. This new innovation marks a significant leap in the field of combat training, introducing an advanced optical filter that consolidates both visible and infrared laser beams into a single, stable beam for enhanced precision in simulation environments.

What Makes the Innovation Unique?

The patented Single ILU Long Pass Filter addresses one of the key limitations in current military training equipment — the frequent misalignment and maintenance issues associated with dual-laser systems. Zen’s new solution offers a compact, rugged, and maintenance-free alternative. The merged beam ensures high alignment accuracy and consistent performance, even in challenging environmental conditions.

Unlike traditional setups, this innovation eliminates the need for two separate laser emitters and a beam combiner. It simplifies the system’s design and enhances reliability — a critical advantage for mobile field simulators and rugged military training deployments.

A Step Forward in India’s Defence Tech Sector

Zen Technologies’ new patent strengthens its position as a pioneer in indigenous defence simulation technology. As India continues to focus on self-reliance in defence manufacturing through the ‘Make in India’ initiative, innovations like these are vital in reducing dependency on foreign technology and increasing export potential.

The compact and modular design of the patented filter makes it ideal for integration into a wide range of simulation systems, from portable infantry simulators to full-scale tactical training environments. This advancement aligns with Zen’s broader strategic objective of delivering state-of-the-art training solutions to armed forces both in India and internationally.

Company Milestones and Global Reach

The company has supplied over 1,000 military training systems across India and to global clients, including institutions such as the U.S. Department of Defense. With in-house R&D and manufacturing capabilities, Zen continues to push boundaries in defence simulation, anti-drone solutions, and tactical training systems.

Market Impact and Future Prospects

The announcement of this patent is expected to bolster investor confidence and further improve Zen’s standing in the defence and technology sectors. The patented filter not only reduces logistical burdens and system downtime but also enhances the realism and tactical accuracy of simulated combat scenarios.

As countries modernize their defence training infrastructure, Zen’s technology is poised to play a critical role in shaping the future of immersive, scalable, and mission-ready training systems.

Disclaimer:

This article is a news report based on publicly available information sourced from credible media outlets and Zen Technologies’ official communications. The information provided herein is for general informational purposes only and does not constitute investment advice or a solicitation to invest in any security or product.

Autonomix Medical Secures Patent for Nerve-Sensing Technology

by

Autonomix Medical, Inc. (NASDAQ: AMIX), a pioneering medtech company focused on nerve-targeted diagnostics and therapies, has been granted a U.S. patent (No. 12,279,889 B2) for its innovative catheter-based nerve-sensing and ablation technology. This marks a major milestone for the company as it continues to expand its intellectual property portfolio and progress toward commercialization.

✅ Cutting-Edge Technology Targeting Hard-to-Treat Conditions

The newly patented device combines microchip sensing arrays, microneedle sensors, optical sensors, and unique microfingers to accurately detect, map, and monitor nerve activity. It is specifically designed to locate small nerves in and around blood vessels and capture real-time electrophysiological signals before, during, and after neuromodulation or radiofrequency (RF) ablation.

This proprietary technology is aimed at addressing a range of serious health conditions linked to overactive sympathetic nervous activity, such as:

Chronic pain (including pancreatic cancer-related pain)

Hypertension

Cardiovascular diseases

Metabolic disorders

Certain neurological conditions

Autonomix’s platform may represent a transformative solution in nerve modulation, with the potential to reduce dependency on opioid-based treatments.

🧪 Next Phase: Clinical Trials in the U.S.

Backed by promising Phase I clinical data demonstrating substantial pain relief and reduced opioid use, Autonomix plans to file for an Investigational Device Exemption (IDE) with the U.S. Food and Drug Administration (FDA). Clinical trials in the United States are scheduled to commence in 2025, with an initial focus on treating pancreatic cancer pain.

While the device is still under investigation and not yet approved for commercial use, these developments underscore its strong potential in a multi-billion-dollar market.

🔒 Strengthened Intellectual Property Portfolio

The issuance of this U.S. patent significantly enhances Autonomix’s competitive standing. The company now holds over 80 patents worldwide, signaling its stronghold in the emerging market of catheter-based nerve therapies. The patent provides exclusive protection in the U.S. for its sensing and ablation system, supporting future licensing opportunities and strategic partnerships.

📉 Financial & Market Context

Despite recent market challenges—Autonomix shares have declined over 65% year-to-date—the company maintains a robust liquidity position and continues to invest in research and development. This patent milestone could serve as a catalyst for investor confidence as the company approaches critical clinical and regulatory phases.

🔍 Key Highlights

Feature Details

Patent No. US 12,279,889 B2
Technology Nerve-sensing + RF ablation catheter system
Clinical Use (Planned) Chronic pain, hypertension, cardiac, metabolic, neuro disorders
Clinical Trial Timeline IDE submission in 2025; U.S. trials to follow
Current Status Investigational; not FDA approved
IP Strength Over 80 patents issued global

📌 Disclaimer

This article is for informational purposes only.

Google’s Pixel 7 Ban: Legal Fallout in Japan

by

In a significant legal development, the Tokyo District Court has issued a sweeping injunction against the sale, import, advertising, and display of Google’s Pixel 7 and Pixel 7 Pro smartphones in Japan. The ruling stems from a patent infringement dispute involving LTE modem technology, marking a notable setback for Google in one of its strongest international markets.—

Patent Dispute: Google vs Pantech and IdeaHub

The legal action was initiated by South Korean telecom equipment company Pantech and Idea Hub, a patent-assertion entity. They claim that Google’s Pixel 7 series infringes on a standard-essential LTE patent—particularly related to the Acknowledgement Signal (ACK) used in 4G communication networks to confirm successful data transmission.According to the court, Google failed to demonstrate good faith in its licensing negotiations. The judgment sharply criticized the company for exhibiting an “insincere attitude” and lacking transparency during the process. This behavior significantly influenced the court’s decision to enforce a full-scale ban.—

Impact of the Injunction

As of now, the Pixel 7 and Pixel 7 Pro are barred from sale, import, and public promotion in Japan. The ruling also extends to the immediate removal of these devices from retail shelves and online marketplaces. Retailers have been instructed to comply or face potential penalties.This legal blow could have far-reaching consequences. Japan constitutes one of Google’s most lucrative markets for Pixel devices, with the brand reportedly commanding over 5% of smartphone market share—second only to Apple.—

Future at Risk: Pixel 8 and Pixel 9 Also in Legal Crosshairs

The plaintiffs have already initiated further proceedings aiming to extend the sales ban to Pixel 8 and the upcoming Pixel 9 models. If successful, Google’s future smartphone launches could face serious delays or disruptions in Japan. Such a ban would significantly hinder Google’s ambitions in the Asian market and may prompt a strategic shift in hardware planning.—

Google’s Options Going Forward

Google now faces three potential paths:1. Appeal the injunction in a higher court to reverse or delay enforcement.2. Negotiate a FRAND (Fair, Reasonable, and Non-Discriminatory) licensing agreement with Pantech and Idea Hub.3. Redesign its LTE modem technology to avoid infringement—a costly and time-consuming process.So far, Google has not issued a public response to the court ruling, but industry analysts expect legal appeals and behind-the-scenes negotiations to unfold in the coming weeks.—

Consumer Advisory

For Japanese consumers and tourists planning to purchase Pixel devices in Japan:Avoid buying Pixel 7/7 Pro as ongoing sales are prohibited. Support and software updates may become limited in the region.Monitor developments for Pixel 8 and Pixel 9, as availability may be impacted.—

Conclusion

This court-ordered ban not only disrupts Pixel 7 sales in Japan but also sets a precedent for how aggressively intellectual property holders can assert rights over essential wireless technologies. Google’s next steps will determine whether its flagship smartphone line can continue its momentum or face further legal and commercial roadblocks in one of Asia’s most technologically advanced nations.

Disclaimer:

This article is for informational purposes only and is based on publicly available sources as of June 2025. All trademarks and intellectual property mentioned herein are the property of their respective owners. The situation is developing, and further legal proceedings may impact the outcome.

Bombay High Court Ruling: CocoPlus vs. Parachute Trade Dress

by

In a significant interim ruling, the Bombay High Court has prohibited Zee Hygiene Products Pvt Ltd, the company behind the “CocoPlus” coconut oil brand, from continuing to use packaging that closely resembles Marico Limited’s well-known “Parachute” product. This development strengthens the enforcement of trade dress rights in India’s FMCG sector.

Presiding over the matter, Justice RI Chagla concluded that the packaging used by CocoPlus bears an unmistakable similarity to that of Parachute, and is likely to cause confusion among ordinary consumers.

Key Observations by the Court

The court pointed out that CocoPlus’s bottle design features several elements that appear to have been directly inspired by Parachute’s iconic presentation. These include:

The blue bottle design

The flag-like coconut tree logo

Imagery of split coconuts with dripping oil

The distinctive color scheme involving blue, green, and white

Justice Chagla remarked that these visual aspects, when combined, create a trade dress that is not only identifiable but also associated closely with Marico’s Parachute brand. The Court held that CocoPlus’s use of similar aesthetics amounted to prima facie imitation and could mislead customers into assuming a connection between the two products.

Defence of Generic Design Rejected

In its response, Zee Hygiene argued that the visual elements it used were common across coconut oil brands and therefore not exclusive to Marico. However, the Court rejected this argument, stating that even commonly used motifs become protectable if they have gained distinctiveness and consumer association over time.

The judge emphasized that the intent to deceive is not required; it is sufficient that a consumer may be misled based on visual resemblance alone.

Temporary Relief with Appeal Option

While the Court passed an order restraining the sale and promotion of CocoPlus in its current packaging, it also granted the company a four-week stay on the injunction. This window allows Zee Hygiene the opportunity to challenge the ruling through an appeal, should they choose to pursue it.

Legal Impact on Trade Dress Enforcement

This judgment is expected to have broader implications for trade dress protection in India. It underlines that brand identity includes more than just logos or names—it also extends to shape, color, imagery, and layout.

The case serves as a reminder to businesses that even partial imitation of a popular product’s look and feel could lead to legal consequences. It also highlights the readiness of Indian courts to safeguard brand equity against potential dilution in the marketplace.

Yamaha Wins Trademark Case: Importance of Acquired Distinctiveness

by
The Delhi High Court has ruled in favor of Yamaha Motor Co., directing the Registrar of Trade Marks to restore a cancelled mark based on a rarely used proviso in Section 201. The decision highlights the importance of acquired distinctiveness and may pave the way for more brand owners to reclaim their legacy trademarks.
The case revolved around Yamaha’s appeal against the Registrar’s decision to cancel one of its trademarks due to non-use. However, the court ruled in Yamaha’s favor by invoking a long-overlooked proviso to Section 201, which permits reinstatement of trademarks that may have acquired distinctiveness in the market—even if they have not been in continuous use.

Court Reaffirms Importance of Acquired Distinctiveness
In its detailed judgment, the Court held that Yamaha’s trademark had developed significant consumer recognition and market goodwill prior to its cancellation. Justice [Name Not Provided] observed that the Trade Marks Registry had failed to consider the acquired distinctiveness of the mark—a crucial element of the proviso to Section 201, which grants the Registrar discretionary power to restore such marks under special circumstances.

“Statutory discretion must be exercised in a holistic manner. Ignoring a valid proviso renders the decision incomplete and flawed,” the Court remarked.

The Court concluded that Yamaha’s mark, by virtue of its prior reputation and public association, was eligible for restoration.

A Rarely Invoked Clause Comes to Light
The proviso to Section 201—originally introduced in a 1960 amendment under the previous law—has seldom been cited in recent decades. It allows the Registrar of Trade Marks to restore a cancelled registration if it can be shown that the mark had acquired a secondary meaning or public recognition, thereby distinguishing itself from common or descriptive terms.

Yamaha’s legal team argued that their mark had become synonymous with their brand offerings and enjoyed widespread familiarity among Indian consumers—well before its removal from the register. The court agreed.

Implications for Brand Owners and IP Law
Legal experts believe the verdict could have a far-reaching impact on how intellectual property authorities interpret restoration requests.

“The judgment sets a precedent for trademarks that might have lapsed due to procedural oversights but still hold value in the public domain,” said an intellectual property law specialist not involved in the case.

The decision also acts as a reminder to the Trade Marks Registry to consider all applicable legal provisions, including discretionary ones, when evaluating such cases.

Legal Community Welcomes Clarification
The judgment is being welcomed as a clarifying moment for Indian trademark law, especially for companies—both Indian and international—looking to safeguard legacy marks. It may also prompt revisions in how the Registry processes applications for restoration.

Yamaha’s success in this case could lead to a wave of similar petitions from brand owners seeking to recover rights over dormant or cancelled marks, particularly those with proven public recognition or historical use.

Disclaimer:
This article is an original and independently written news report based on the public judgment and legal reporting available through LiveLaw. It has been paraphrased and reconstructed for clarity, legal accuracy, and to ensure it is free from plagiarism. For further reference, readers may consult the original coverage at LiveLaw.

Innovative Biofuel from Sugarcane: Revolutionizing Renewable Energy in India

by

A young innovator from Maharashtra has made headlines after developing a sustainable biofuel derived from sugarcane juice. Kanak Talware, a final-year student of chemical engineering at Jawaharlal Nehru Engineering College, part of MGM University, has been granted a patent by the Indian government for her unique process that converts sugarcane into clean-burning bioethanol.

The innovation is being celebrated as a potential game-changer in India’s transition toward renewable energy and rural fuel self-sufficiency.

🌱 Turning Sugarcane into Sustainable Fuel
Talware’s patented system enables the efficient extraction and conversion of sugarcane juice into ethanol, which can be used as a biofuel. The technology is tailored to be cost-effective and scalable, especially for use in agricultural areas where sugarcane is grown in abundance.

“This project was motivated by a desire to offer farmers a way to generate energy and income locally while also contributing to environmental goals,” said Kanak in a statement.

Her method reduces dependency on fossil fuels while promoting green alternatives that align with India’s sustainable development goals.

👩‍🏫 Guided Innovation and Institutional Backing
The project received academic support and guidance from MGM University’s faculty members, including Dr. Ravindra Gaikwad and Akash Vani, and was developed in collaboration with experts from Pravara Rural Engineering College, notably Dr. Annasaheb Varade and Ravindra Nibe.

Supporting India’s Clean Fuel Goals
India has made significant strides in ethanol-blended fuel, with over 50 million tonnes of carbon dioxide emissions already avoided through biofuel adoption. The central government aims to achieve 20% ethanol blending in petrol by 2025–26.

Talware’s innovation contributes directly to this mission by offering a renewable, locally sourced fuel solution that could benefit both the environment and sugarcane farmers.

🔍 Future Prospects
The patented technology now awaits further development for commercial application, including:

Pilot-scale production and testing.

Potential tie-ups with fuel companies and green startups.

Integration into rural energy models for wider social impact.
Disclaimer:
This article is an original, independently written report based on public information and journalistic reinterpretation of a story originally covered by India Today. It has been paraphrased and rewritten for clarity, originality, and SEO purposes. For more details, readers are encouraged to refer to the source article published on IndiaToday.in.

Harley-Davidson X350 Patent Revealed in India

by

In an exciting development for motorcycle enthusiasts, the patent for the Harley-Davidson X350 has surfaced in India, sparking widespread speculation about the potential launch of the entry-level roadster in the domestic market. Developed in collaboration with Chinese partner Qianjiang Motor, the X350 is Harley-Davidson’s strategic attempt to expand its footprint in the small-displacement motorcycle segment globally.

What is the Harley-Davidson X350?

The Harley-Davidson X350 is a neo-retro roadster aimed at riders seeking a stylish yet accessible option under the iconic American brand. Originally launched in China, and later introduced in Australia and Japan, the X350 features a 353cc liquid-cooled parallel-twin engine that delivers approximately 36 horsepower and 31 Nm of torque. It comes with a 6-speed gearbox, dual-channel ABS, and upside-down front forks, all packed into a chassis that weighs around 180–195 kg.

India Patent Filing and Market Implications

The surfacing of the patent in India indicates Harley-Davidson’s serious intent to gauge market readiness for the X350. While there is no official confirmation from Harley-Davidson or Hero MotoCorp (its Indian manufacturing partner), the move hints at strategic groundwork being laid for a potential entry.

The X350’s patent in India comes amid the successful run of the Harley-Davidson X440—a single-cylinder cruiser co-developed with Hero MotoCorp and currently the brand’s most affordable model in the Indian market. If launched locally and aggressively priced through Hero’s manufacturing facilities, the X350 could be a game-changer in the mid-capacity motorcycle segment, competing with models like the Royal Enfield Meteor 350, Honda CB350, and KTM 390 Duke.

Expected Price and Launch Timeline

Globally, the Harley-Davidson X350 is priced at approximately CNY 33,388 (around ₹3.9 lakh). If launched in India with deep localization, industry analysts predict a competitive pricing of ₹2.4–3.5 lakh (ex-showroom). However, without substantial localization, the X350 may remain a niche offering due to higher import duties.

Mixed Reactions from Enthusiasts

While some Harley loyalists express reservations about the X350’s Chinese origins, others welcome the idea of a more affordable and modern Harley. Enthusiasts are divided—some see it as a departure from traditional Harley design philosophy, while others view it as a fresh, accessible evolution in the brand’s portfolio.

This news article is based on publicly available information and reports regarding the recent surfacing of a Harley-Davidson X350 patent in India. While no official confirmation has been provided by Harley-Davidson or Hero MotoCorp about its launch in India, the filing of the patent suggests potential future developments. Readers are advised to stay tuned for official announcements. The information presented here is accurate as of the date of publication and subject to change.

OmniActive Sues Bio‑Gen for Patent Infringement Over Eye Health Ingredients

by

OmniActive Health Technologies, a leading global supplier of clinically studied health and wellness ingredients, has filed a patent infringement lawsuit against Indian nutraceutical firm Bio‑Gen Extracts Pvt. Ltd. in the U.S. District Court for the Eastern District of Texas.

The lawsuit centers on U.S. Patent No. 10,532,035, owned by OmniActive, which protects a proprietary formulation method for combining marigold-derived lutein and zeaxanthin isomers—key carotenoids known to support eye health. This patented technology is at the core of OmniActive’s flagship product, Lutemax® 2020, a premium eye health ingredient used in supplements worldwide.

Allegations Against Bio‑Gen Extracts

According to court filings, OmniActive alleges that Bio‑Gen’s product Lute‑gen® unlawfully uses its patented formulation method. The company claims Bio‑Gen has knowingly infringed upon several claims of its patent, specifically relating to the unique composition and ratio of lutein and zeaxanthin isomers.

OmniActive is seeking:

A jury trial

Compensatory and enhanced damages

Legal cost reimbursement

A permanent injunction against further infringement by Bio‑Gen

The plaintiff emphasized its commitment to safeguarding innovation and customer trust. “We invest heavily in research, clinical validation, and patent protection to provide high-quality, science-backed ingredients.

About the Patented Ingredient – Lutemax® 2020

Lutemax® 2020 is a marigold-derived extract that contains all three macular carotenoids—lutein, RR-zeaxanthin, and RS (meso)-zeaxanthin—in the same ratio as found in nature. Supported by multiple clinical studies, the ingredient has been widely recognized for promoting visual function, reducing eye fatigue, and combating the effects of blue light exposure.

What This Means for the Nutraceutical Industry

This case shines a spotlight on the growing competition and innovation within the nutraceutical and dietary supplement sector. Patent protection is becoming increasingly critical as companies invest in proprietary formulations to differentiate themselves in a crowded market.

About the Companies Involved

OmniActive Health Technologies Ltd.

Headquartered in Mumbai, India, with a major U.S. presence in Bridgewater, New Jersey, OmniActive is known for developing science-driven, clinically validated ingredients. Its portfolio includes actives for eye health, brain function, metabolism, and skin wellness.

Bio‑Gen Extracts Pvt. Ltd.

Based in India, Bio‑Gen is a botanical extract and nutraceutical ingredient manufacturer. Its product Lute‑gen® is marketed as a natural source of lutein and zeaxanthin for eye health supplements.